Community Update: Votoplam data from long-term extention study (Phase 2 LTE)katie8288Apr 280 min read
Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients
Comments